Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-345-2 | CAS number: 2128-93-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07 September 2017 - 10 November 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 4-phenylbenzophenone
- EC Number:
- 218-345-2
- EC Name:
- 4-phenylbenzophenone
- Cas Number:
- 2128-93-0
- Molecular formula:
- C19H14O
- IUPAC Name:
- {[1,1'-biphenyl]-4-yl}(phenyl)methanone
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
Batch No.of test material:
20161118
- Expiration date of the lot/batch:
22 November 2018
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material:
At room temperature protected from light
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Crl: WI(Han)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Females (if applicable) nulliparous and non-pregnant: [yes/no]
not specified - checking with lab.
- Age and weight at study initiation:
males were 10 weeks old and weighed between 273 and 316 g and females were 13 weeks old and weighed between 202 and 248 g.
- Housing:
On arrival and following the pre-test (females only) and pre-mating period, animals were group housed (up to 5 animals of the same sex and same dosing group together) in polycarbonate cages. During the mating phase, males and females were cohabitated on a 1:1 basis in Macrolon plastic cages. During the post-mating phase, males were housed in their home cage with a maximum of 5 males/cage. Females were individually housed in Macrolon plastic cages. During the lactation phase, females were housed in Macrolon plastic cages. Pups were housed with the dam.
- Diet (e.g. ad libitum):
ad libitum
- Water (e.g. ad libitum):
ad libitum
- Acclimation period:
8 days prior to start of the pre-test period (females) or 10 days before the commencement of dosing (males).
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
18 to 24°C
- Humidity (%):
40 to 70%
- Air changes (per hr):
Ten or greater air changes per hour with 100% fresh air (no air recirculation)
- Photoperiod (hrs dark / hrs light):
12 hour light/12 hour dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on mating procedure:
- After 14 days of treatment, animals were cohabitated on a 1:1 basis within the same treatment group, avoiding sibling mating. Detection of mating was confirmed by evidence of sperm in the vaginal lavage or by the appearance of an intravaginal copulatory plug. This day was designated Day 0 post-coitum. Once mating had occurred, the males and females were separated. A maximum of 14 days was allowed for mating, after which females who had not shown evidence of mating were separated from their males.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analysis for concentration, homogeneity and stability were undertaken on duplicate samples.
- Duration of treatment / exposure:
- Once daily oral gavage 7 days a week for a minimum of 29 days.
Males were treated for 29 days (2 weeks prior to mating, during mating, and up to and including the day before scheduled necropsy).
Females that delivered were treated for 50 - 56 days (most females) or 64 days (one female of Group 3), (14 days prior to mating (with the objective to cover at least two complete estrous cycles), the variable time to conception, the duration of pregnancy and 13-15 days after delivery, up to and including the day before scheduled necropsy).
Females which failed to deliver or had a total litter loss were treated for 39-43 days (Group 4) or 41-54 days (Groups 2 and 3). - Frequency of treatment:
- Once daily oral gavage 7 days a week for a minimum of 29 days.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 10/sex/dose
- Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
DETAILED CLINICAL OBSERVATIONS: Yes
BODY WEIGHT: Yes
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
WATER CONSUMPTION: Yes
HAEMATOLOGY: Yes
- Anaesthetic used for blood collection: Yes (identity) / No / Not specified
- Animals fasted: Yes / No / Not specified
- How many animals:
- Parameters checked in table [No.?] were examined.
CLINICAL CHEMISTRY: Yes
NEUROBEHAVIOURAL EXAMINATION: Yes
- Battery of functions tested: Hearing ability, Pupillary reflex, Static righting reflex, Fore- and hind-limb grip strength, Locomotor activity. - Oestrous cyclicity (parental animals):
- Estrous cycles were evaluated by examining the vaginal cytology of samples obtained by vaginal lavage.
Daily vaginal lavage was performed for all females beginning 14 days prior to treatment (pretest period), the first 14 days of treatment and during mating until evidence of copulation was observed. Vaginal lavage was continued for those females with no evidence of copulation until termination of the mating period.
On the day of necropsy, a vaginal lavage was also taken to determine the stage of estrus. This was done for all females, except for one female with total litter loss. - Sperm parameters (parental animals):
- Parameters examined in P male parental generation: testis weight, epididymis weight.
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 8 pups/litter of equal sex; excess pups were killed and discarded. Whenever the number of male or female pups prevented having four of each sex per litter, partial adjustment (for example, five males and three females) was acceptable.
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: number and sex of pups, stillbirths, live births, postnatal mortality, anogenital distance (AGD), presence of nipples/areolae in male pups and clinical biochemistry.
GROSS EXAMINATION OF DEAD PUPS: yes, for external abnormalities; possible cause of death was not determined for pups born or found dead.
- Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals [describe when, e.g. as soon as possible after the last litters in each generation were produced.]
- Maternal animals: All surviving animals [describe when, e.g. after the last litter of each generation was weaned.]
GROSS NECROPSY
- Gross necropsy consisted of [external and internal examinations including the cervical, thoracic, and abdominal viscera.]
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Table 1 were prepared for microscopic examination and weighed, respectively. - Statistics:
- All pairwise comparisons were conducted using two sided tests and were reported at the 1% and 5% levels.
Descriptive statistics number, mean and standard deviation (or %CV or SE when deemed appropriate) were reported whenever possible.
The following pairwise comparisons were made:
Group 2 vs. Group 1
Group 3 vs. Group 1
Group 4 vs. Group 1
Parametric: Datasets with at least 3 groups (the designated control group and 2 other groups) were compared using Dunnett-test (many-to-one-t-test).
Non-Parametric: Datasets with at least 3 groups was compared using a Steel-test (many-to-one rank test). The motor activity data set was compared using an overall Kruskal-Wallis.
Incidence: An overall Fisher’s exact test was used to compare all groups at the 5% significance level. The above pairwise comparisons were conducted using Fisher’s exact test whenever the overall test is significant.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No toxicologically relevant clinical signs were noted up to treatment with 1000 mg/kg.
- Mortality:
- no mortality observed
- Description (incidence):
- One female (no. 73) at 1000 mg/kg was sacrificed at PND 1 due to total litter loss.
- Body weight and weight changes:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Mean body weights and body weight gain of females at 1000 mg/kg were statistically significantly reduced at Days 17 and 20 of the post-coitum period. At the end of this period, mean body weight of 1000 mg/kg females was 19% lower than that of controls. This could be explained by the different physiological status (former pregnancy but no live offspring).
- Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- Females at 1000 mg/kg consumed less food than controls between Days 17-20 of the post-coitum period (statistically significant). This correlated with their lower body weight and was related to the different physiological status (former pregnancy but no live offspring).
No treatment-related changes in food consumption before or after allowance for body weight were observed in males treated up to 1000 mg/kg and females treated at 100 mg/kg. - Water consumption and compound intake (if drinking water study):
- no effects observed
- Haematological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The lower number of neutrophils and mean corpuscular volume (MCV) noted in 1000 mg/kg females were related to the physiological status of these females.
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- In males at 1000 mg/kg bw, statistically significant differences were noted for alkaline phosphatase (ALP) activity (lower) and chloride (higher). These findings were not accompanied by adverse anatomic pathology alterations and the mean values for these parameters in 1000 mg/kg bw males remained within the historical control ranges . As such, these clinical pathology changes were regarded as non-adverse.
In lactating females, isolated statistically significant differences were noted for glucose (lower at 100 and 300 mg/kg bw) and sodium (higher at 300 mg/kg bw). These differences were considered to be unrelated to treatment as they showed no dose-related trend (glucose) and/or remained within normal limits.
Clinical chemistry values in females treated at 1000 mg/kg bw showed the following statistically significant differences from concurrent controls, all considered to be related to the difference in physiological status (percentage differences were not calculated due to the difference in physiological status). It cannot be determined if values in 1000 mg/kg bw females remained within the normal range, since no historical control data is available for females with implantation sites only. Query with lab. - Urinalysis findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Query with lab.
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Substance-related microscopic findings were noted in the thyroid glands of both sexes and adrenal glands of females.
In the thyroid gland, follicular cell hypertrophy was observed at increased incidence and severity (up to slight) in 300 mg/kg males and in 1000 mg/kg rats of both sexes.
In the adrenal gland, inflammatory cell infiltrate (minimal) was observed in 1000 mg/kg females. This infiltrate mainly consisted of lymphocytes and was located at the zona fasciculata (and sometimes zona reticularis) of the adrenal cortex.
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Length and regularity of the estrous cycle were not affected by treatment.
Any effects seen were incidental and in the absence of a dose-related incidence, these findings did not indicate a relation with treatment. - Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- effects observed, treatment-related
- Description (incidence and severity):
- There were no morphological findings in the reproductive organs of males which could be attributed to the test item, and stage aware evaluation of the testes did not show any indication for abnormal spermatogenesis.
Couples without offspring at 100 and 300 mg/kg bw:
One couple (out of 10) at 100 mg/kg bw and 1/10 couples at 300 mg/kg bw had no offspring. No abnormalities were seen in the reproductive organs which could account for their lack of offspring.
Couples without offspring at 1000 mg/kg bw:
Females of the 1000 mg/kg group had no offspring (except for one female which had two dead pups at first litter check). There were 2/9 females without evidence of former pregnancy and 7/9 females with evidence of former pregnancy. The latter seven females showed small/old implantation sites, none to minimal lobuloalveolar development of the mammary gland and histologic proof of a normal estrus cycle. The lack of healthy offspring in the 1000 mg/kg bw group was considered to be test item-related.
Mating index and precoital time was not affected by treatment.
The mean number of implantation sites was statistically significantly decreased at 1000 mg/kg bw (9.5 versus 13.0 in controls).
Treatment at 100 or 300 mg/kg bw did not affect the number of implantation sites.
The fertility indices were 100, 90, 90 and 80% for the control, 100, 300 and 1000 mg/kg bw groups, respectively.
Effect levels (P0)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: a decrease in the number of implantation sites at 1000 mg/kg.
Target system / organ toxicity (P0)
- Key result
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 300 mg/kg bw/day (nominal)
- System:
- female reproductive system
- Treatment related:
- yes
- Dose response relationship:
- yes
- Relevant for humans:
- yes
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No clinical signs occurred among pups that were considered to be related to treatment.
- Mortality / viability:
- mortality observed, treatment-related
- Description (incidence and severity):
- The single 1000 mg/kg female with offspring had only dead pups (two) at first litter check (total litter loss).
At 300 mg/kg, there were four pups that died postnatally (versus 0 in the control group; this difference was statistically significant).
Two pups went missing (presumably cannibalized) at PND 2 (litter nos. 62 and 69), one was found dead at PND 2 (litter no. 62) and one was euthanized for humane reasons at PND 1 (litter no. 68). At 100 mg/kg, one pup was euthanized for humane reasons (PND 3, litter no. 53). This postnatal loss remained within the range considered normal for pups of this age, however, was in the upper limit of considered normal range and may be test item related together with the other findings in developmental data. Therefore a treatment related effect cannot be excluded. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- At 300 mg/kg, mean body weights of male and female pups were lower compared to controls from PND 4 (9% difference) until the end of the lactation period (about 17% difference at PND 13). Statistical significance was achieved from PND 7 onwards. Mean body weight of male 300 mg/kg pups was also lower at birth (PND 1) whereas birth weight of female 300 mg/kg pups was close to the control value (8 and 5% difference, respectively).
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- Serum T4 levels in male and female PND 14-16 pups were judged to be unaffected by treatment up to 300 mg/kg (T4 measurements were not conducted at higher doses).
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
Effect levels (F1)
- Key result
- Dose descriptor:
- LOAEL
- Generation:
- F1
- Effect level:
- 100 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- mortality
- other: reduced post-implantation survival and decreased live litter size
Target system / organ toxicity (F1)
- Key result
- Critical effects observed:
- yes
- Lowest effective dose / conc.:
- 100 mg/kg bw/day (nominal)
- Organ:
- not specified
- Treatment related:
- yes
- Dose response relationship:
- yes
- Relevant for humans:
- yes
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- yes
- Lowest effective dose / conc.:
- 300 mg/kg bw/day (nominal)
- Treatment related:
- yes
- Relation to other toxic effects:
- reproductive effects occurring together with other toxic effects, but not as a secondary non-specific consequence of other toxic effects
- Dose response relationship:
- yes
- Relevant for humans:
- yes
Applicant's summary and conclusion
- Conclusions:
- In conclusion, based on the results of the combined 28-day repeated dose toxicity study with the reproduction/developmental toxicity screening test, the following No Observed Adverse Effect Levels (NOAELs) of the substance were established:
Parental NOAEL: at least 1000 mg/kg.
Reproduction NOAEL: 300 mg/kg, based on a decrease in the number of implantation sites at 1000 mg/kg.
Developmental NOAEL: Below 100 mg/kg, based on reduced post-implantation survival and decreased live litter size starting at 100 mg/kg.
- Executive summary:
The potential toxic effects of the substance when given orally by gavage for a minimum of 28 days to Wistar Han rats and the potential to affect male and female reproductive performance such as gonadal function, mating behaviour, conception, parturition and early postnatal development was determined in a 28-day repeated dose toxicity study with the reproduction/developmental toxicity screening test according to OECD TG 422. The dose levels were 0, 100, 300 and 1000 mg/kg/day, based on the results of the dose range finder. No parental toxicity was observed up to the highest dose level tested (1000 mg/kg). Reproductive toxicity was observed at 1000 mg/kg as indicated by a reduced number of implantation sites. There were no morphological findings in the reproductive organs of either sex which could explain these effects. Developmental toxicity was observed at 100, 300 and 1000 mg/kg. At 1000 mg/kg, none of the eight pregnant females had healthy offspring. One of them had two dead pups at first litter check and seven had no offspring but showed proof of former pregnancy. At 100 and 300 mg/kg, post-implantation survival index and live litter size were reduced. In conclusion, based on the results of this study, the parental NOAEL was determined to be at least 1000 mg/kg. Reproduction NOAEL was 300 mg/kg, based on a decrease in the number of implantation sites at 1000 mg/kg. Developmental NOAEL was considered to be below 100 mg/kg, based on reduced post-implantation survival and decreased live litter size starting at 100 mg/kg. At 1000 mg/kg no pups were available for evaluation of postnatal development.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.